Analyst Ratings for IMS Health Holdings Inc (IMS)

Updated: 2016-10-01

Several price targets were given for IMS by the analysts covering the stock. The highest price target was 34, implying a possible profit of 8.49 percent. The lowest price target was 25, which equates to a potential downside of -20.23 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is 2.78 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 1.91 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

The growth rate of IMS's earnings is estimated by analysts to be 277.44 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, because people typically see that as an indicator of higher growth relative to stock price. Wall Street investors typically prefer a PEG ratio to be smaller than 1, though it could be better to see where the ratio stands relative to peers in the industry. IMS has a PEG ratio of 0.27.

IMS has traded between a high of 31.59 and a low of 22.36 over the past year. Today's price is 40.16 percent above the 52-week low, and 0.79 percent below the high. IMS has a P/E ratio of 75.45. Investors typically compare the P/E ratio to a company's peers in the industry. The IMS value stock report compares IMS to some of its peers using value stock charts. The market cap of IMS is $10.59 billion. IMS will post this quarters earnings in -816 days, on 2016-10-27.